site stats

Biosyent investor

WebSep 29, 2024 · BioSyent climbed a long way after the early 2024 pandemic pullback. The stock went from about $3.20 to $8.00 before the year was out. But 2024 has been a bit of … WebAug 23, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and are subject to risks and uncertainties that may cause actual results or outcomes to be …

BioSyent Schedules Q4 and Full Year 2024 Earnings Release for …

WebOct 28, 2013 · BioSyent only has 13.5 million shares outstanding (14.5m FD), 43% controlled by the management and the board. BioSyent's CEO Rene Goehrum owns 18% of the company, and CFO Alfred D'Souza owns 11%. Mr. WebMar 9, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are … phoebe waller-bridge amazon se https://tfcconstruction.net

BioSyent: A Great Micro Cap (OTCMKTS:BIOYF) Seeking Alpha

WebFeb 24, 2024 · 1.3% of BioSyent shares are held by institutional investors. 40.6% of BioSyent shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. WebShares of BioSyent are available in the United States on the OTC Pink Marketplace under the trading symbol BIOYF. 2. Looking for general information about your shares? All … WebMar 21, 2024 · MISSISSAUGA, Ontario, March 21, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and … phoebe wallace bridge

Biosyent is undervalued, this investor says - Cantech Letter

Category:FAX Capital Announces Investment in BioSyent Inc., Files

Tags:Biosyent investor

Biosyent investor

BioSyent Announces Grant of Restricted Share Units

http://www.biosyent.com/rx/investor_center/ WebMar 31, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and are subject to risks and uncertainties that may cause actual results or outcomes to be …

Biosyent investor

Did you know?

WebBioSyent is continuously is looking to source pharmaceutical products that have been successfully developed and proven to be safe and effective. BioSyent then … WebBioSyent is continuously is looking to source pharmaceutical products that have been successfully developed and proven to be safe and effective. BioSyent then …

WebMar 31, 2024 · For further information please contact: Mr. René C. Goehrum President and CEO BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com This press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and … WebMar 24, 2024 · BioSyent Inc. is a Canada-based pharmaceutical company. The Company is focused on in-licensing or acquiring pharmaceutical and other healthcare products. It owns a legacy business that manufactures and markets Protect-It, a bio-friendly non-toxic product used in agriculture, which is operated by its subsidiary Hedley Technologies Ltd.

http://www.biosyent.com/rx/investors_financials/ WebApr 26, 2024 · MISSISSAUGA, Ontario, April 26, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2024 Bloom Burton & Co ...

http://www.biosyent.com/rx/investor_facts/

WebMar 21, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and are subject to risks and uncertainties that may cause actual results or outcomes to be … phoebe waller-bridge amazon serittc gm new lookWebSep 14, 2024 · René Goehrum, President and CEO of BioSyent, will present to investors an overview of BioSyent’s business and corporate activities. The MicroCap Leadership Summit is attended by retail and ... ttc gmbh berlinWebApr 14, 2024 · René Goehrum, President and CEO of BioSyent, will present to investors an overview of BioSyent’s business and corporate activities on April 21 at 11:00 am. Mr. Goehrum will also be available to ... ttcg loginWebMar 9, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are forward-looking. The contents herein ... phoebe waller-bridge and martin mcdonaghWebMar 19, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. TRENDING. Yahoo TV 'Succession' storylines reportedly inspired by Fox News owner Rupert Murdoch's family. phoebe waller-bridge amazon serieWebMar 9, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are … phoebe waller-bridge and olivia colman